American Century NT Large Co Val G (ACLLX)

12.01 -0.02  -0.17% Dec 13 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 12.01
Turnover Ratio 56.00%
1 Year Fund Level Flows -341.64M

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 2.56% 2.04% 13
3M 4.87% 5.10% 49
6M 9.29% 9.83% 49
YTD 26.81% 23.32% 15
1Y 20.05% 16.98% 18
3Y 8.95% 9.09% 48
5Y 8.43% 8.38% 51
10Y 10.90% 10.81% 51
15Y -- 7.33% --
20Y -- 6.94% --
As of Dec. 13, 2019. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 2.11% 2.11% 0.00%
Stock 97.89% 97.89% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Sept. 30, 2019

Region Exposure

Americas 89.09%
North America 89.09%
Latin America 0.00%
Greater Europe 10.00%
United Kingdom 1.74%
Europe Developed 8.27%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.91%
Japan 0.90%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.00%
% Emerging Markets 0.00%
As of Sept. 30, 2019. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 2.16%
Communication Services 3.62%
Consumer Cyclical 4.42%
Consumer Defensive 10.96%
Energy 8.05%
Financial Services 24.32%
Healthcare 19.42%
Industrials 9.40%
Real Estate 3.54%
Technology 7.88%
Utilities 6.21%
As of Sept. 30, 2019

Stock Market Capitalization

Giant 45.77%
Large 42.38%
Medium 11.80%
Small 0.05%
Micro 0.00%
As of Sept. 30, 2019

Stock Style Exposure

Large Cap Value 53.43%
Large Cap Blend 31.45%
Large Cap Growth 3.28%
Mid Cap Value 7.02%
Mid Cap Blend 4.70%
Mid Cap Growth 0.07%
Small Cap Value 0.03%
Small Cap Blend 0.01%
Small Cap Growth 0.01%
As of Sept. 30, 2019
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
MDT Medtronic PLC 4.06% 113.52 +1.01%
ZBH Zimmer Biomet Holdings Inc 3.42% 148.07 +0.45%
VZ Verizon Communications Inc 3.41% 60.81 -0.59%
PG Procter & Gamble Co 3.24% 125.47 +0.72%
PFE Pfizer Inc 3.22% 38.33 -0.54%
JNJ Johnson & Johnson 3.18% 141.38 +0.03%
PNC PNC Financial Services Group Inc 3.18% 158.64 -0.23%
BRK.B Berkshire Hathaway Inc B 2.99% 225.37 -0.24%
JPM JPMorgan Chase & Co 2.94% 136.81 -0.88%
TOT Total SA ADR 2.65% 52.96 -0.32%
As of Sept. 30, 2019
Advertisement

Basic Info

Investment Strategy
The investment seeks long-term capital growth; income is a secondary consideration. The fund invests primarily in larger companies. Under normal market conditions, the portfolio managers will invest at least 80% of the fund's net assets in equity securities of companies comprising the Russell 1000® Index. The fund is not permitted to invest in securities issued by companies assigned the Global Industry Classification Standard (GICS) or the Bloomberg Industry Classification Standard (BICS) for the tobacco industry.
General
Security Type Mutual Fund
Oldest Share Symbol ACLLX
Equity Style Large Cap/Value
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Large Value
Prospectus Objective Growth
Fund Owner Firm Name American Century Investments
Benchmark Index
Russell 1000 Value TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Brian Woglom 3.56 yrs
Philip Sundell 0.26 yrs
Phillip Davidson 1.25 yrs

Net Fund Flows

1M -29.82M
3M -89.87M
6M -173.21M
YTD -262.45M
1Y -341.64M
3Y -767.46M
5Y -574.11M
10Y 98.21M
As of Nov. 30, 2019

Risk Info

Beta (5Y) 0.9867
Historical Sharpe Ratio (10Y) 0.8622
Historical Sortino (All) 0.4024
Daily Value at Risk (VaR) 1% (All) 3.55%
Monthly Value at Risk (VaR) 1% (All) 14.66%

Fundamentals

Dividend Yield TTM (12-13-19) 2.49%
30-Day SEC Yield (11-30-19) 0.00%
7-Day SEC Yield (4-23-09) 0.00%
Weighted Average PE Ratio 16.71
Weighted Average Price to Sales Ratio 1.917
Weighted Average Price to Book Ratio 2.150
Weighted Median ROE 16.75%
Weighted Median ROA 5.54%
Forecasted Dividend Yield 2.87%
Forecasted PE Ratio 15.37
Forecasted Price to Sales Ratio 1.874
Forecasted Price to Book Ratio 2.008
Number of Holdings 65
As of Sept. 30, 2019

Growth Estimates

Forecasted 5 Yr Earnings Growth 6.87%
Forecasted Book Value Growth 5.79%
Forecasted Cash Flow Growth 10.58%
Forecasted Earnings Growth 16.45%
Forecasted Revenue Growth 4.15%
As of Sept. 30, 2019

Comparables

Edit

Attributes

Purchase Details
Open to New Investors No
Open to Existing Investors Yes
Minimum Initial Investment 0.00 USD
Minimum Subsequent Investment 0.00 USD
Fees
Actual 12B-1 Fee --
Actual Management Fee 0.48%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 5/12/2006
Termination Date
Last Annual Report Date 3/31/2019
Last Prospectus Date 8/1/2019
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.